MDxHealth SA Stock Euronext Bruxelles
Equities
MDXH
BE0974461940
Biotechnology & Medical Research
Sales 2024 * | 78.5M 85.6M | Sales 2025 * | 89.88M 98.02M | Capitalization | 69.81M 76.14M |
---|---|---|---|---|---|
Net income 2024 * | -26M -28.35M | Net income 2025 * | -17M -18.54M | EV / Sales 2024 * | 0.89 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.78 x |
P/E ratio 2024 * |
-2.77
x | P/E ratio 2025 * |
-4.15
x | Employees | 300 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.92% |
Latest transcript on MDxHealth SA
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 19-02-17 | |
Ron Kalfus
DFI | Director of Finance/CFO | 50 | 19-07-21 |
Miriam Reyes
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Donnie Hardison
BRD | Director/Board Member | 73 | 21-09-28 |
Eric Bednarski
BRD | Director/Board Member | 52 | 20-07-29 |
Hilde Windels
BRD | Director/Board Member | 59 | 17-10-31 |
1st Jan change | Capi. | |
---|---|---|
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |